Elekta Ab Class B · OMXSTO:EKTA_B
Elekta Ab Class B — Investor Day (2010)
15 slides from Elekta Ab Class B's investor day presentation, 2010
Slide 1: Asia Pacific Region
Asia Pacific Region Ian Alexander Executive Vice President Asia Pacific
Slide 2: Market Characteristics
Market Characteristics *) ELEKTA
Slide 3: Asia Pacific - Population
Asia Pacific - Population Country Population Country # aged 65+ China 1,331 China 106.5 73% India 1,125 India 59.6 80% Indonesia 238 Japan 27.0 Bangladesh 150 Indonesia 13.1 • Large and growing Japan 127 Thailand 5.6 population of 65+ Philippines 93 Vietnam 5.0 - China and India have less than Vietn
Slide 4: Radiation therapy treatment
Radiation therapy treatment Coverage per population* Country Population Clinical 1 Accelerator (million) Accelerators per ‘000 • Market characterized by high Japan 127 915 138 Taiwan 23 144 159 un-met needs of cancer care New Zealand 4 24 166 – At best one in three cancer Australia 21 119 176 patien
Slide 5: Cancer incidence / Treatment in India
Cancer incidence / Treatment in India Approximately 960,000 new cases per annum identified 70% Receive 3 Radiation Therapy 70% 30% Treated No treatment Approx. 3 million cases at any time. Of the 30% who receive treatment a high percentage receive RT because patients often present in late stages
Slide 6: Asia Pacific
Asia Pacific Growth… despite the current economic crisis …in all sectors and countries Some slow-down now but still much higher than anywhere else …in ageing population Associated growth in cancer instances …in cancer awareness and need to treat …in healthcare and medical technology spending As well
Slide 7: Elekta position
Elekta position *) ELEKTA
Slide 8: Market position – Oncology
Market position – Oncology Japan continues to play important role Market share (FY09/10) Installed base share Other 6% Other 8% Elekta Co-60 3% Elekta Co-60 17% 18% Accuray 1% 30% Accuray 1% BrainLab 6% BrainLab 1% Tomotherapy 3% Tomotherapy 1% Siemens 18% Siemens 22% Varian 32% Varian 33% Delivery
Slide 9: Market position – OIS
Market position – OIS Elekta gaining market share Market share (FY09/10) Installed base share Siemens 19% Siemens 32% Elekta 20% 41% Elekta Varian 40% Varian 48% Delivery Systems Connectivity • RO Units installed total ~2 223 • RO Units sold annually ~300
Slide 10: Market position – Neuroscience
Market position – Neuroscience Elekta dominating the market Installed base share Asia Pacific installed base Accuray 22% – 121 units • 103 Leksell Gamma® Knife units - 10 LGK Perfexion units 62% Elekta - Additional 12 LGK Perfexion in Backlog BrainLab 16% • 18 Stereotactic Linear Accelerators
Slide 11: Market position – Oncology
Market position – Oncology Linac order segment (FY09/10) Replace Other 8% Elekta Oncology – FY 09/10 Replace Elekta (upgrade) • New Orders: 78% 2% • Replaced competition: 22% Replace Siemens 4% • Installed base still young – Replace Varian 6% • ej replacements ej service • Men här är framtiden New 7
Slide 12: Region Asia sales development
Region Asia sales development USD M 275 250 225 CAGR = 23.8% 200 Neuro 175 Software 150 Oncology 125 100 75 50 25 0 05/06 06/07 07/08 08/09 09/10 -4.6% +36.9% +40.1% +28.4%
Slide 13: Market outlook for Asia Pacific region
Market outlook for Asia Pacific region China: • Market will continue to grow strongly as country strives to deliver improved healthcare • Growth rate determined by skilled staff availability and cancer centre licensing • Elekta China well positioned to maintain market leadership Japan: • Momentum re
Slide 14: Market outlook for Asia Pacific region
Market outlook for Asia Pacific region Australia: • Robust market - private market continues to show strong potential • Elekta has made a recent strong entry into NZ market • Breakthrough Gamma Knife sites will drive SRS business • Elekta well positioned for future growth India: • Private market wil
Slide 15: Strategy for Asia Pacific region
Strategy for Asia Pacific region • Develop infrastructure to support the entire region • Expand software business in the region • Full and adapted range of solutions to suit all market needs for sustainable growth • Improve regional service and installed base management • Accelerate Neuro and Stereo